InGel Therapeutics, Inc.
www.ingeltx.comInGel Therapeutics is Harvard-spinoff, cell-therapy biotech leveraging the novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities include dry AMD and Glaucoma.
Read more
InGel Therapeutics is Harvard-spinoff, cell-therapy biotech leveraging the novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities include dry AMD and Glaucoma.
Read more
Employees statistics
View all employeesPotential Decision Makers
Co - Founder and Chief Business Officer
Email ****** @****.comPhone (***) ****-****Founder and Chairman of the Board
Email ****** @****.comPhone (***) ****-****Tv and Digital Director
Email ****** @****.comPhone (***) ****-****Investor and Board Advisor
Email ****** @****.comPhone (***) ****-****
Reach decision makers at InGel Therapeutics, Inc.
Free credits every month!
InGel Therapeutics, Inc. FAQ
United States
Biotechnology Research
